Targeting cardiac hypertrophy through a nuclear co‐repressor
Heart failure entails the inability of the heart to pump blood to vital organs. One of the main risk factors for heart failure is the development of pathological hypertrophy. In this issue of EMBO Molecular Medicine, Li and coworkers show that NCoR1, a co‐repressor of transcription factors, inhibits...
Main Authors: | Andrea Grund, Joerg Heineke |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-11-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201911297 |
Similar Items
-
Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
by: Fiona Eitner, et al.
Published: (2022-01-01) -
TBLR1 regulates the expression of nuclear hormone receptor co-repressors
by: Brown Stuart, et al.
Published: (2006-08-01) -
The Nuclear Receptor—Co-repressor Complex in Control of Liver Metabolism and Disease
by: Ning Liang, et al.
Published: (2019-06-01) -
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-11-01) -
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
by: Andrea Grund, et al.
Published: (2019-10-01)